Skip to content
This website uses cookies to help us understand the way visitors use our website. We can't identify you with them and we don't share the data with anyone else. If you click Reject we will set a single cookie to remember your preference. Find out more in our privacy policy.

New Chair for UCLPartners Cardiovascular Academic Medical Centre announced

23 November 2016

Steffen Petersen portraitProfessor Steffen Petersen has been appointed as Chair of the UCLPartners Cardiovascular Academic Medical Centre. He takes on the role this month from Professor Mark Caulfield who is stepping down after three years in post.

As Chair, Steffen is responsible for leading the ongoing development of UCLPartners Academic Health Science Centre’s (AHSC) strategy for cardiovascular health, supporting world-class research, education and enterprise.

Steffen studied medicine at the University of Mainz in Germany and has worked in clinical practice in cardiology since graduating in 1998. He received a DPhil in 2005.  Steffen is Professor of Cardiovascular Medicine at Queen Mary University of London, where he leads on large scale clinical trials and population based studies using cardiac imaging.

Professor David Lomas, Academic Director of UCLPartners and Vice-Provost (Health) at UCL, said: “I am delighted to welcome Steffen to this important leadership role within the AHSC.  Steffen brings a wealth of cardiovascular research expertise and an excellent track record in population studies to this role.  I am confident this will enable him to harness the world-class academic and clinical cardiovascular expertise that exists across the partnership and to build on the progress and achievements already made.”

“I would also like to take this opportunity to thank Mark Caulfield, who has chaired the Cardiovascular Academic Medical Centre at UCLPartners since 2013 and successfully supported a partnership approach to discovery science in cardiovascular health.”

UCLPartners Cardiovascular Academic Medical Centre brings together expertise from across partner hospitals and universities to speed up the development of new treatments, diagnostics and prevention strategies for cardiovascular health.